On December 17th, DMALL (02586) spent 1.902 million Hong Kong dollars to repurchase 269,100 shares.
Multipoint Technology (02586) announced that it will spend HK$1.902 million to repurchase 26.91 million shares on December 17, 2025.
DMALL (02586) announces that on December 17, 2025, it has spent 1.902 million Hong Kong dollars to repurchase 26.91 thousand shares.
Related Articles
BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.
RECBIO-B (02179) completes the directed issuance of domestic shares.
TRANSTECH (09963) plans to discount approximately 11.85% of the allotment, with a maximum of 52 million shares, raising approximately HK$244 million net.
BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.
RECBIO-B (02179) completes the directed issuance of domestic shares.
TRANSTECH (09963) plans to discount approximately 11.85% of the allotment, with a maximum of 52 million shares, raising approximately HK$244 million net.
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025
